-
UK to launch research studies to develop long Covid therapies
pharmaceutical-technology
July 20, 2021
The UK Government has announced plans to commence a research programme comprising of 15 new studies to develop new therapies for long Covid and enhance diagnosis.
-
Digital transformation: Pharma’s pivot for post-pandemic success
expresspharma
July 20, 2021
Shashank Kumar, Senior Consultant, Cloud Engineering Studio, Brillio, explains how digital and data analytics tools are helping pharma businesses.
-
Boris Johnson to Self-Isolate After Coronavirus Exposure
drugs
July 20, 2021
After facing an uproar, British Prime Minister Boris Johnson says he will spend 10 days self-isolating after contact with a confirmed coronavirus case.
-
Pediatricians' Group: All School Kids, Staff Should Continue to Wear Masks
drugs
July 20, 2021
All U.S. students, teachers and staff should wear masks when in school, regardless of their vaccination status, the American Academy of Pediatrics (AAP) said Monday.
-
Canada Surpasses U.S. COVID-19 Vaccination Rates
drugs
July 20, 2021
COVID-19 vaccination rates in Canada have now beaten those in the United States.
-
Court Blocks Lifting of COVID-19 Restrictions on Cruise Ships
drugs
July 20, 2021
A federal appeals court has ruled that Florida-based cruise ships will be able to keep COVID-19 pandemic restrictions in place for now.
-
U.S. Surgeon General Backs Local Mask Mandates When Needed
drugs
July 20, 2021
U.S. Surgeon General Vivek Murthy, M.D., said Sunday that he supports reinstating local mask mandates when they are needed to curb the spread of COVID-19 among unvaccinated people.
-
ASH Suggests Not Using Outpatient Thromboprophylaxis for COVID-19
drugs
July 20, 2021
A new draft recommendation relating to anticoagulation for discharged patients with COVID-19 has been issued by the American Society of Hematology (ASH).
-
Covid-19: At-risk children to be offered Pfizer/BioNTech vaccine
firstwordpharma
July 20, 2021
UK health secretary Sajid Javid said children who are at increased risk of COVID-19 will be offered Pfizer/BioNTech's vaccine on the NHS "as soon as possible," as are those who are immunocompromised, as reported in This is Money.
-
Statement on offering COVID-19 vaccines to at-risk young people
firstwordpharma
July 20, 2021
Today’s advice from the independent Joint Committee on Vaccination and Immunisation (JCVI) means more vulnerable young people at greatest risk from this virus can now benefit from COVID-19 vaccines.